Key result
Both weight loss and gain >5% over 2 years in patients with type 2 diabetes were associated with increased risks of MI, ischemic stroke, AF, heart failure, and all-cause death (all P<0.0001).
Why the study?
Despite the metabolic benefits of weight loss in patients with T2DM, its association with MI, ischemic stroke, AF, HF, and all-cause death remains elusive.
Does weight change (loss or gain) increase the risk of major cardiovascular events in patients with T2DM?
Cohort (n=1,522,241)
Yes
Does weight change (loss or gain) increase the risk of major cardiovascular events in patients with T2DM?
p-value: p=<0.0001
In patients with T2DM, both significant weight loss and weight gain over a 2-year period are associated with increased risks of major cardiovascular events and mortality, suggesting that weight stability may be associated with the lowest cardiovascular risk.
Supports weight stability in T2DM; leaves open causality and need for RCTs on weight interventions.
OBJECTIVE: Despite the benefits of weight loss on metabolic profiles in patients with type 2 diabetes mellitus (T2DM), its association with myocardial infarction (MI), ischemic stroke (IS), atrial fibrillation (AF), heart failure (HF), and all-cause death remains elusive. RESEARCH DESIGN AND METHODS: Using the National Health Insurance Service Database, we screened subjects who underwent general health checkups twice in a 2-year interval between 2009 and 2012. After identifying 1,522,241 patients with T2DM without a previous history of MI, IS, AF, and HF, we followed them until December 2018. Patients were stratified according to the magnitude of weight changes between two general health checkups: ≤ -10%, -10 to ≤ -5%, -5 to ≤5%, 5 to ≤10%, and >10%. RESULTS: During the follow-up (median 7.0 years), 32,106 cases of MI, 44,406 cases of IS, 34,953 cases of AF, 68,745 cases of HF, and 84,635 all-cause deaths occurred. Patients with weight changes of -5 to ≤5% showed the lowest risk of each cardiovascular event. Both directions of weight change were associated with an increased cardiovascular risk. Stepwise increases in the risks of MI, IS, AF, HF, and all-cause death were noted with progressive weight gain (all P < 0.0001). Similarly, the more weight loss occurred, the higher the cardiovascular risks observed (all P < 0.0001). The U-shaped associations were consistently observed in both univariate and multivariate analyses. Explorative subgroup analyses also consistently showed a U-shaped association. CONCLUSIONS: Both weight loss and gain >5% within a 2-year interval were associated with an increased risk of major cardiovascular events in patients with T2DM.
No takes yet. Share an insight, caveat, or question.
Park et al. (2022) conducted a cohort in Type 2 Diabetes Mellitus (n=1,522,241). Body weight changes (weight loss or gain >5%) vs. Weight changes of -5 to ≤5% was evaluated on Myocardial infarction, ischemic stroke, atrial fibrillation, heart failure, and all-cause death (p=<0.0001). Both weight loss and gain >5% over 2 years in patients with type 2 diabetes were associated with increased risks of MI, ischemic stroke, AF, heart failure, and all-cause death (all P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: